Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 19 results.
User Information
Export Records
  1. 1.   The CXCR4 antagonist plerixafor corrects panleukopenia in patients with WHIM syndrome
  2. McDermott, D. H.; Liu, Q.; Ulrick, J.; Kwatemaa, N.; Anaya-O'Brien, S.; Penzak, S. R.; Oliveira, J.; Priel, D. A. L.; Kelly, C.; Garofalo, M.; Littel, P.; Marquesen, M. M.; Hilligoss, D.; DeCastro, R.; Fleisher, T. A.; Kuhns, D. B.; Malech, H. L.; Murphy, P. M.
  3. Blood. 2011, Nov; 118(18): 4957-4962.
  1. 2.   Antiangiogenic agents and HIF-1 inhibitors meet at the crossroads
  2. Rapisarda, A.; Shoemaker, R. H.; Melillo, G.
  3. Cell Cycle. 2009, Dec; 8(24): 4040-4043.
  1. 3.   Photo-activation of the hydrophobic probe iodonaphthylazide in cells alters membrane protein function leading to cell death
  2. Viard, M.; Garg, H.; Blumenthal, R.; Raviv, Y.
  3. BMC Cell Biology. 2009 10 AR 21
  1. 4.   The anti-cancer compound Nordy inhibits CXCR4-mediated production of IL-8 and VEGF by malignant human glioma cells
  2. Ping, Y. F.; Yao, X. H.; Chen, J. H.; Liu, H.; Chen, D. L.; Zhou, X. D.; Wang, J. M.; Bian, X. W.
  3. Journal of Neuro-Oncology. 2007, Aug; 84(1): 21-29.
  1. 5.   Brain-derived neurotrophic factor prevents the nigrostriatal degeneration induced by human immunodeficiency virus-1 glycoprotein 120 in vivo
  2. Nosheny, R. L.; Ahmed, F.; Yakovlev, A.; Meyer, E. M.; Ren, K.; Tessarollo, L.; Mocchetti, I.
  3. European Journal of Neuroscience. 2007, Apr; 25(8): 2275-2284.
  1. 6.   Physiological levels of virion-associated human immunodeficiency virus type 1 envelope induce coreceptor-dependent calcium flux
  2. Melar, M.; Ott, D. E.; Hope, T. J.
  3. Journal of Virology. 2007, Feb; 81(4): 1773-1785.
  1. 8.   Risk for HIV-1 infection associated with a common CXCL12 (SDF1) polymorphism and CXCR4 variation in an African population
  2. Petersen, D. C.; Glashoff, R. H.; Shrestha, S.; Bergeron, J.; Laten, A.; Gold, B.; van Rensburg, E. J.; Dean, M.; Hayes, V. M.
  3. Jaids-Journal of Acquired Immune Deficiency Syndromes. 2005, DEC 15; 40(5): 521-526.
  1. 9.   Haplotype analysis of the SDF-1 (CXCL12) gene in a longitudinal HIV-1/AIDS cohort study
  2. Modi, W. S.; Scott, K.; Goedert, J. J.; Vlahov, D.; Buchbinder, S.; Detels, R.; Donfield, S.; O'Brien, S. J.; Winkler, C.
  3. Genes and Immunity. 2005, DEC; 6(8): 691-698.
  1. 10.   Marked structural and functional heterogeneity in CXCR4: Separation of HIV-1 and SDF-I alpha responses
  2. Sloane, A. J.; Raso, V.; Dimitrov, D. S.; Xiao, X. D.; Deo, S.; Muljadi, N.; Restuccia, D.; Turville, S.; Kearney, C.; Broder, C. C.; Zoellner, H.; Cunningham, A. L.; Bendall, L.; Lynch, G. W.
  3. Immunology and Cell Biology. 2005 83(2): 129-143.
  1. 11.   Angiogenic effects of prostaglandin E-2 are mediated by up- regulation of CXCR4 on human microvascular endothelial cells
  2. Salcedo, R.; Zhang, X.; Young, H. A.; Michael, N.; Wasserman, K.; Ma, W. H.; Martins-Green, M.; Murphy, W. J.; Oppenheim, J. J.
  3. Blood. 2003 102(6): 1966-1977.
  1. 12.   Tannic acid is an inhibitor of CXCL12 (SDF-1 alpha)/CXCR4 with antiangiogenic activity
  2. Chen, X.; Beutler, J. A.; McCloud, T. G.; Loehfelm, A.; Yang, L.; Dong, H. F.; Chertov, O. Y.; Salcedo, R.; Oppenheim, J. J.; Howard, O. M. Z.
  3. Clinical Cancer Research. 2003 9(8): 3115-3123.
  1. 13.   Role of chemokines in angiogenesis: CXCL12/SDF-1 and CXCR4 interaction, a key regulator of endothelial cell responses
  2. Salcedo, R.; Oppenheim, J. J.
  3. Microcirculation. 2003 10(3-4): 359-370.
  1. 14.   Suradista NSC 651016 inhibits the angiogenic activity of CXCL12-stromal cell-derived factor 1 alpha
  2. Schneider, G. P.; Salcedo, R.; Dong, H. F.; Kleinman, H. K.; Oppenheim, J. J.; Howard, O. M. Z.
  3. Clinical Cancer Research. 2002 8(12): 3955-3960.
  1. 15.   Up-regulation of HIV coreceptor CXCR4 expression in human T lymphocytes is mediated in part by a cAMP-responsive element
  2. Cristillo, A. D.; Highbarger, H. C.; Dewar, R. L.; Dimitrov, D. S.; Golding, H.; Bierer, B. E.
  3. Faseb Journal. 2002 16(3): 354-364.
  1. 16.   Nonpathogenic lion and puma lentiviruses impart resistance to superinfection by virulent feline immunodeficiency virus
  2. Vande Woude, S.; Hageman, C. A.; O'Brien, S. J.; Hoover, E. A.
  3. Journal of acquired immune deficiency syndromes (1999). 2002 29(1): 1-10.
  1. 17.   Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells - In vivo neovascularization induced by stromal-derived factor-1 alpha
  2. Salcedo, R.; Wasserman, K.; Young, H. A.; Grimm, M. C.; Howard, O. M. Z.; Anver, M. R.; Kleinman, H. K.; Murphy, W. J.; Oppenheim, J. J.
  3. American Journal of Pathology. 1999 154(4): 1125-1135.
  1. 18.   The promise of comparative genomics in mammals
  2. O'Brien, S. J.; Menotti-Raymond, M.; Murphy, W. J.; Nash, W. G.; Wienberg, J.; Stanyon, R.; Copeland, N. G.; Jenkins, N. A.; Womack, J. E.; Graves, J. A. M.
  3. Science. 1999 286(5439): 458-+.
  1. 19.   Hiv Coreceptors
  2. Dimitrov, D. S.; Xiao, X.; Chabot, D. J.; Broder, C. C.
  3. Journal of Membrane Biology. 1998 166(2): 75-90.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel